Inhibition of prostaglandin H2 synthases by salicylate is dependent on the oxidative state of the enzymes

Advances in Experimental Medicine and Biology

Volumn 525, Issue , 2003, Pages 125-128

  Aronoff, David M ^a   Boutaud, Olivier ^b   Marnett, Lawrence J ^c   Oates, John A ^d  

^a Division of Infectious Diseases   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ISOENZYME; LIPID PEROXIDE; PROSTAGLANDIN SYNTHASE; SALICYLIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; SALICYLIC ACID DERIVATIVE;

CATALYSIS; CONFERENCE PAPER; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME PURIFICATION; IN VIVO STUDY; MOLECULAR INTERACTION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REDUCTION; ARTICLE; CHEMISTRY; METABOLISM;

CYCLOOXYGENASE INHIBITORS; LIPID PEROXIDES; OXIDATION-REDUCTION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SALICYLATES;

EID: 0037980424     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9194-2_25     Document Type: Conference Paper

References (13)

1. Humes JL, Winter CA, Sadowski SJ and Kuehl FA, Jr. Multiple sites on prostaglandin eyclooxygenase are determinants in the action of nonsteroidal antiinflammatory agents. Proc Natl Acad Sci U S A 1981; 78:2053-6.
2. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ and Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 1994; 90:11693-7
3. Mitchell JA, Saunders M, Barnes PJ, Newton R and Belvisi MG. Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid. Molecular Pharmacology 1997; 51:907-12
4. Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E and Guay J. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal antiinflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 1997; 75:1088-95
5. Amann R, Egger T, Schuligoi R, Heinemann A and Peskar BA. Sodium salicylate enhances the expression of cyclooxygenase-2 in endotoxin-stimulated human mononuclear cells. Eur J Pharmacol 2001; 433:129-34.
6. Giuliano F, Mitchell JA and Warner TD. Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo. J Pharmacol Exp Ther 2001; 299:894-900.
7. Boutaud O, Aronoff DM, Richardson JH, Marnett LJ and Oates JA. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases. Proceedings of the National Academy of Sciences 2002; 99:7130-7135
8. Hemler ME, Lands WE. Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem 1980; 255:6253-61.
9. Hanel AM, Lands WE. Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides. Biochem Pharmacol 1982;31:3307-11.
10. Ouellet M, Percival MD. Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Archives of Biochemistry and Biophysics 2001; 387:273-280
11. Markey CM, Alward A, Weller PE and Marnett LJ. Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. Reducing substrate specificity and the relationship of peroxidase to cyclooxygenase activities. J Biol Chem 1987; 262:6266-79.
12. Odenwaller R, Chen YN and Marnett LJ. Preparation and proteolytic cleavage of apoprostaglandin endoperoxide synthase. Methods in Enzymology 1990; 187:479-85
13. Odenwaller R, Maddipati KR and Marnett LJ. Detection of a higher oxidation state of manganese-prostaglandin endoperoxide synthase. Journal of Biological Chemistry 1992; 267:13863-9.